Scholar Rock Holding SRRK
NASDAQ SRRK
$55.33 -0.61 (-1.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Scholar Rock Holding (SRRK) EBIT (2017 - 2026)

Scholar Rock Holding (SRRK) posted quarterly EBIT of -$102.0 million for Q1 2026, down 32.33% year-over-year from -$150.8 million in Q1 2025, and down 11.01% quarter-over-quarter from -$91.9 million in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) EBIT (2017 - 2026) Analysis & Trends

Scholar Rock Holding's EBIT history runs 10 years deep, the most recent figure standing at -$102.0 million for Q1 2026.

  • In Q1 2026, EBIT fell 32.33% year-over-year to -$102.0 million; the TTM figure through Mar 2026 stood at -$409.6 million (down 51.29% YoY), while the FY2025 annual figure was -$384.6 million, down 52.6% from the prior year.
  • EBIT for Q1 2026 stood at -$102.0 million, down from -$91.9 million in the prior quarter.
  • The five-year high for EBIT was -$6.9 million in Q1 2022, with the low at -$112.1 million in Q2 2025.
  • The 5-year median for EBIT is -$58.4 million (2024), against an average of -$61.4 million.
  • The sharpest annual moves came in 2022 and 2023: EBIT jumped 74.52% in 2022, then plunged 484.29% in 2023.
  • Scholar Rock Holding's EBIT stood at -$40.4 million in 2022, then declined by 18.81% to -$48.0 million in 2023, then slumped by 44.4% to -$69.4 million in 2024, then slumped by 32.5% to -$91.9 million in 2025, then decreased by 11.01% to -$102.0 million in 2026.
  • Business Quant data shows SRRK's EBIT at -$102.0 million in Q1 2026, -$91.9 million in Q4 2025, and -$103.6 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 493.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -815.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 325.05 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 231.44 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 133.12 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -1.55 Mn
10 Scholar Rock Holding 7.24 Bn 7.24 Bn - -108.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -108.90 Mn
Mar 31, 2026 -102.02 Mn
Dec 31, 2025 -91.90 Mn
Sep 30, 2025 -103.55 Mn
Jun 30, 2025 -112.11 Mn
Mar 31, 2025 -77.09 Mn
Dec 31, 2024 -69.36 Mn
Sep 30, 2024 -64.78 Mn
Jun 30, 2024 -59.50 Mn
Mar 31, 2024 -58.42 Mn
Dec 31, 2023 -48.03 Mn
Sep 30, 2023 -43.67 Mn
Jun 30, 2023 -39.08 Mn
Mar 31, 2023 -40.51 Mn
Dec 31, 2022 -40.43 Mn
Sep 30, 2022 -43.86 Mn
Jun 30, 2022 -43.15 Mn
Mar 31, 2022 -6.93 Mn
Dec 31, 2021 -35.36 Mn
Sep 30, 2021 -37.08 Mn